Leucine Rich Bio, now unveils its #HappyGutMission campaign an initiative designed to educate people on the critical role of gut health. This campaign has brought gut health to the forefront, offering ...

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for serious diseases, announced top-line ...

Exports of Ayush and herbal products for the first six months of the current fiscal has reported a 10.34 per cent growth, as ...

Harbour BioMed submits IND application for HBM9378/SKB378 to China NMPA to treat chronic obstructive pulmonary disease: Suzhou, China Monday, November 11, 2024, 17:00 Hrs [IST] Ha ...

Dr Jayachandra Babu Ramapuram has been honoured with the prestigious AAPS Fellow Award at the American Association of Pharmaceutical Scientists (AAPS) annual meeting held in Salt Lake City, Utah. This ...

IceCure Medical Ltd., a developer of minimally-invasive cryoablation technology that destroys tumours by freezing as an alternative to surgical tumour removal, announced the US Food and Drug ...

Robles BioCeutics collaborates with BioCentrium to explore the molecular mechanisms behind Glowselle stem cell activator: San Diego Monday, November 11, 2024, 16:00 Hrs [IST] Robl ...

UDF to organize experts meeting towards creation of Indian Pharmaceutical Regulatory Service cadre: Shardul Nautiyal, Mumbai Monday, November 11, 2024, 16:45 Hrs [IST] New Delhi b ...

Nammi Therapeutics begins patient dosing in phase 1 study of QXL138AM for advanced solid tumours and multiple myeloma: Los Angeles Monday, November 11, 2024, 13:00 Hrs [IST] Nammi ...

Johnson & Johnson announced the submission of regulatory applications to the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) seeking approval of a new indication for Darzalex ...

US FDA clears SystImmune’s IND application for BL-M17D1 in advanced solid tumours: Redmond, Washington Monday, November 11, 2024, 14:00 Hrs [IST] SystImmune, Inc (SystImmune), a ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...